ContentsSynopsisCodesDifferential Diagnosis & PitfallsBest TestsReferences
Libman-Sacks endocarditis
Other Resources UpToDate PubMed

Libman-Sacks endocarditis

Contributors: Benjamin L. Mazer MD, MBA, Ryan Hoefen MD, PhD, Jeffrey P. Callen MD, FACP, MAAD, MACR
Other Resources UpToDate PubMed

Synopsis

Libman-Sacks endocarditis is a noninfective cardiac valve disease that was initially described in patients with systemic lupus erythematosus (SLE). After the recognition that antiphospholipid antibodies were associated with this phenomenon frequently, it has become possible that this form of endocarditis might occur in patients with antiphospholipid antibody syndrome in the absence of a diagnosis of SLE. Vegetations on cardiac valves in Libman-Sacks endocarditis are composed primarily of inflammatory cells and fibrin clots. Endocarditis is presumed to be caused by autoimmunity against a cardiac valve with concurrent hypercoagulability. Patients are often asymptomatic but may be discovered after a cardioembolism causes ischemic injury, such as stroke or peripheral embolic disease. Libman-Sacks endocarditis is most frequently on the mitral and/or aortic valves. It may cause valve dysfunction.

Treatment includes anticoagulation, immunosuppression for active SLE, and valve replacement in cases complicated by severe dysfunction.

Codes

ICD10CM:
M32.11 – Endocarditis in systemic lupus erythematosus

SNOMEDCT:
54072008 – Nonbacterial verrucal endocardiosis

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

References

Subscription Required

Last Updated:05/02/2022
Copyright © 2022 VisualDx®. All rights reserved.
Libman-Sacks endocarditis
Print  
Libman-Sacks endocarditis : Exertional dyspnea, Heart murmur, Dyspnea, Asthenia
Copyright © 2022 VisualDx®. All rights reserved.